(Q73301403)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

title

Gemifloxacin and ciprofloxacin pharmacodynamics in an in-vitro dynamic model: prediction of the equivalent AUC/MIC breakpoints and doses (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

A A Firsov

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S H Zinner

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Lubenko IYu

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S N Vostrov

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Antimicrobial Agents

2 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

page(s)

407-414

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

Prediction of the antimicrobial effects of trovafloxacin and ciprofloxacin on staphylococci using an in-vitro dynamic model

2 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

Comparative pharmacodynamics of gatifloxacin and ciprofloxacin in an in vitro dynamic model: prediction of equiefficient doses and the breakpoints of the area under the curve/MIC ratio

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

Comparison of the antibacterial activities of the quinolones Bay 12-8039, gatifloxacin (AM 1155), trovafloxacin, clinafloxacin, levofloxacin and ciprofloxacin

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

Comparative in-vitro activity of the new fluoroquinolone trovafloxacin (CP-99,219) against gram-positive cocci

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

In-vitro activity of trovafloxacin, a new fluoroquinolone, against recent clinical isolates

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

In-vitro and in-vivo antibacterial activity of CFC-222, a new fluoroquinolone.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

In-vitro activity of OPC-17116 against more than 6000 consecutive clinical isolates: a multicentre international study.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

In vitro activity of BAY 12-8039, a new fluoroquinolone, against species representative of respiratory tract pathogens.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

Pharmacokinetics and tolerability of gemifloxacin (SB-265805) after administration of single oral doses to healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

Pharmacokinetics of ciprofloxacin after oral and parenteral administration

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

The comparative pharmacokinetics of five quinolones

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

Parameters of bacterial killing and regrowth kinetics and antimicrobial effect examined in terms of area under the concentration-time curve relationships: action of ciprofloxacin against Escherichia coli in an in vitro dynamic model.

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

Inter- and intraquinolone predictors of antimicrobial effect in an in vitro dynamic model: new insight into a widely used concept

1 reference

https://api.crossref.org/works/10.1016%2FS0924-8579%2800%2900226-0

7 January 2021

10.1016/S0924-8579(00)00226-0

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11118849%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference